Tyrodin Tablet

About Tyrodin 60 mg Tablet

Tyrodin is a 60 mg tablet made by Advanced Chemical Industries PLC. It contains cinacalcet, a calcium regulator used in certain parathyroid and kidney-related hormone problems. Treatment is supervised by a doctor.

There are 3 brands of Cinacalcet listed in Bangladesh.

What is Tyrodin 60 mg Tablet?

Tyrodin 60 mg tablet is manufactured by Advanced Chemical Industries PLC and contains the active ingredient cinacalcet, which belongs to a group called calcium regulators. It works as a calcimimetic agent: it makes the parathyroid gland more sensitive to calcium, which lowers parathyroid hormone secretion. This in turn lowers calcium and phosphorus levels in the blood. It is used only under medical supervision for specific hormone and calcium problems linked to the parathyroid gland and chronic kidney disease. The doctor decides whether it is suitable and how it should be taken.

Uses of Tyrodin

Tyrodin is used for three main conditions. It treats secondary hyperparathyroidism in people with chronic kidney disease who are on dialysis. It also treats high blood calcium in people with parathyroid carcinoma. In addition, it is used for high blood calcium in primary hyperparathyroidism when calcium remains high after the parathyroid gland has been removed. The doctor confirms the diagnosis and decides if this medicine is appropriate.

How to use Tyrodin

Tyrodin is a tablet taken by mouth. The doctor decides the dose, how often it is taken and how long the course lasts, and may adjust it over time based on blood tests. Swallow the tablet as your doctor or pharmacist advises. Do not change the dose yourself. Regular blood tests for calcium and parathyroid hormone are part of treatment, and the doctor will tell you when these are needed. Ask your pharmacist about storage.

Side effects of Tyrodin

Common side effects include nausea, vomiting, loss of appetite, dizziness, tingling, weakness, muscle pain and rash. Reduced testosterone levels have also been reported. Less common effects include indigestion, diarrhoea and seizures, and low blood pressure and heart failure have been reported. Tell your doctor promptly if you feel unwell or notice any side effect. Your doctor will advise on what to do and whether treatment needs to change.

Safety and precautions

Do not take Tyrodin if you are allergic to any of its ingredients. The doctor checks blood calcium before and during treatment and will not start it if calcium is low. Regular monitoring of calcium and parathyroid hormone is needed. Use in pregnancy only if the doctor judges the benefit outweighs the risk. Breast-feeding should be discontinued during treatment. Tell your doctor about all your medicines and health conditions. Ask your doctor or pharmacist first if you have any concerns.

Frequently asked questions

What is Tyrodin used for and what kind of medicine is it?

Tyrodin is a calcium regulator containing cinacalcet. It is used for secondary hyperparathyroidism in people with chronic kidney disease on dialysis, and for high blood calcium in parathyroid carcinoma or after parathyroid gland removal. The doctor decides if it suits you.

Who should avoid Tyrodin or ask the doctor first?

Anyone allergic to its ingredients should avoid it. The doctor will not start it if blood calcium is low. Tell your doctor if you are pregnant, breast-feeding, or have other health conditions. Ask your doctor or pharmacist first if you are unsure whether it is suitable for you.

Which medicines may interact with Tyrodin?

Tyrodin may interact with amitriptyline, nortriptyline, desipramine and tacrolimus. Medicines such as ketoconazole and erythromycin may raise its blood level. Tell your doctor or pharmacist about all medicines you take, including over-the-counter ones, before starting treatment.

Does Tyrodin need regular blood tests?

Yes. The doctor checks blood calcium before starting and at intervals during treatment, and also checks parathyroid hormone levels. These tests help the doctor adjust the dose. Follow your doctor's advice on when to have tests and do not skip appointments.

Indications

Cinacalcet is indicated in-
  • For the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis
  • For the treatment of hypercalcemia in patients with parathyroid carcinoma
  • For the treatment of hypercalcaemia in patients with primary hyperparathyroidism who still have high calcium level after removal of the parathyroid gland

Pharmacology

Cinacalcet is a calcimimetic agent. It lowers parathyroid hormone (PTH) secretion by increasing the sensitivity of the calcium-sensing receptor of the parathyroid gland to activation by extracellular calcium. PTH reduction leads to concomitant decrease in serum calcium and phosphorus concentrations.

Dosage & Administration

Hypercalcaemia associated with parathyroid carcinoma or primary hyperparathyroidism: ≥18 yr, initial: 30 mg bid. Titrate dose every 2-4 wk in sequential doses of 60 mg bid, 90 mg bid, and 90 mg 3-4 times daily as needed until serum calcium levels normalised. Max: 90 mg 4 times/day.

Secondary hyperparathyroisim in patients with chronic kidney disease on dialysis: ≥18 yr, initial: 30 mg once daily. Titrate dose every 2-4 wk in steps of 30 mg as necessary to achieve intact parathyroid hormone (iPTH) levels of 150-300 pg/mL. Max: 180 mg once daily. May be used alone or in combination with vitamin D sterols and/or phosphate binders.

Interaction

Cinacalcet is a strong CYP2D6 inhibitor and may increase serum concentrations of amitriptyline, nortriptyline and desipramine. Cinacalcet may decrease serum concentrations of tacrolimus. CYP3A4 inhibitors such as ketoconazole, erythromycin may increase plasma concentrations of Cinacalcet.

Contraindications

Cinacalcet is contraindicated in patients with hypersensitivity to any components of this product.

Side Effects

The common side effects of Cinacalcet are nausea, vomiting, anorexia; dizziness, paraesthesia, asthenia; reduced testosterone concentrations; myalgia; rash; less commonly dyspepsia, diarrhoea, and seizures; hypotension and heart failure also reported.

Pregnancy & Lactation

There are no adequate and well-controlled studies in pregnant women. Cinacalcet should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It Only for the use of Medical Professionals is not known whether this drug is excreted in human milk. Considering the potential for clinically significant adverse reactions in infants from Cinacalcet; it is recommended that breast-feeding be discontinued during treatment with Cinacalcet.

Precautions & Warnings

Cinacalcet treatment should not be initiated if serum calcium is less than the lower limit of the normal range (8.4 mg/dL). Serum-calcium concentration should be measured before initiation of treatment and within 1 week after starting treatment or adjusting dose, then monthly for secondary hyperparathyroidism and every 2–3 months for primary hyperparathyroidism and parathyroid carcinoma; treatment should not be initiated in patients with hypocalcaemia; in secondary hyperparathyroidism PTH concentration should be measured 1–4 weeks after starting treatment or adjusting dose, then every 1–3 months; dose adjustment may be necessary if smoking started or stopped during treatment; hepatic impairment; pregnancy.

Overdose Effects

Overdosage may lead to hypocalcaemia. Provide treatment to correct serum calcium levels. Haemodialysis are unlikely to be useful.

Storage Conditions

Store in a cool dry place below 30ºC. Protect from light

Alternative brands of Cinacalcet

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.